1. Home
  2. PGEN vs BDMD Comparison

PGEN vs BDMD Comparison

Compare PGEN & BDMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • BDMD
  • Stock Information
  • Founded
  • PGEN 1998
  • BDMD 2012
  • Country
  • PGEN United States
  • BDMD China
  • Employees
  • PGEN N/A
  • BDMD N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • BDMD
  • Sector
  • PGEN Health Care
  • BDMD
  • Exchange
  • PGEN Nasdaq
  • BDMD NYSE
  • Market Cap
  • PGEN 512.5M
  • BDMD 133.4M
  • IPO Year
  • PGEN N/A
  • BDMD N/A
  • Fundamental
  • Price
  • PGEN $1.74
  • BDMD $5.51
  • Analyst Decision
  • PGEN Buy
  • BDMD
  • Analyst Count
  • PGEN 5
  • BDMD 0
  • Target Price
  • PGEN $7.00
  • BDMD N/A
  • AVG Volume (30 Days)
  • PGEN 2.0M
  • BDMD 90.4K
  • Earning Date
  • PGEN 05-13-2025
  • BDMD 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • BDMD N/A
  • EPS Growth
  • PGEN N/A
  • BDMD 578.78
  • EPS
  • PGEN N/A
  • BDMD 0.43
  • Revenue
  • PGEN $3,963,000.00
  • BDMD $33,048,249.00
  • Revenue This Year
  • PGEN N/A
  • BDMD N/A
  • Revenue Next Year
  • PGEN $420.64
  • BDMD N/A
  • P/E Ratio
  • PGEN N/A
  • BDMD $12.40
  • Revenue Growth
  • PGEN N/A
  • BDMD N/A
  • 52 Week Low
  • PGEN $0.65
  • BDMD $1.05
  • 52 Week High
  • PGEN $2.17
  • BDMD $13.52
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 51.69
  • BDMD N/A
  • Support Level
  • PGEN $1.66
  • BDMD N/A
  • Resistance Level
  • PGEN $1.95
  • BDMD N/A
  • Average True Range (ATR)
  • PGEN 0.18
  • BDMD 0.00
  • MACD
  • PGEN -0.03
  • BDMD 0.00
  • Stochastic Oscillator
  • PGEN 30.36
  • BDMD 0.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Share on Social Networks: